Kannaway is a subsidiary of Medical Marijuana Inc. that – through Kannaway Slovakia – offers quality FDA-tested CBD products for everyday use to Slovakians who want to improve their overall wellbeing and lifestyle.
Kannaway was founded in 2014 in the United States with the European head office opening in 2018, which supports Kannaway Slovakia. The company’s founding principle is to bring the safest and best-quality cannabis-based – or cannabidiol (CBD), the non-psychoactive cannabinoid – product innovations to market.
Kannaway manufactures products based on CBD hemp oil of the highest standard, including the versatile nutritional supplement Pure Gold, which is the preferred CBD product of choice of for tens of thousands of satisfied customers all over the world.
As is the case in many other industry segments that experience a rush of product innovation, the rise in popularity of CBD products has resulted in small enterprises engaging in a media assault on their larger rivals. This often involves the spread of misinformation about competitors and their products. Instead of embracing the fact that there are plenty of customers all over the world who are interested in CBD products – enough for all legitimate CBD companies – these enterprises choose an aggressive and unfair approach to competing with others in the same industry.
Sadly, Kannaway has been the subject of such malpractice in Slovakia. In particular, fake news about third-party tests published on Slovakian websites that seek to discredit the legitimacy of Kannaway CBD products. In this article, we will address the false claims made by the companies that have sought to spread misinformation about Kannaway CBD products.
Misinformation from MediCann Slovakia and Arge Canna
CBD enterprise, MediCann Slovakia bases its false claims on material produced by its partner in Austria, Arge Canna – another CBD enterprise. Both use the words “medicine” and “healthcare” in connection with their companies and their services or products. And this one of the fundamental differences between these entities and Kannaway.
Kannaway has many doctors and medical professionals in its organisation, but in no way refers to itself as a healthcare company or markets its products as medicine and strongly advises its Brand Ambassadors against doing so. Kannaway has no interest in competing with these companies because it targets a different market segment – people who use CBD products daily as a dietary supplement to improve their overall wellbeing.
Kannaway has many doctors and medical professionals in its Therefore, the so-called “lab reports” carried out by Arge Canna and its “partner laboratories” that compare Kannaway Pure Gold oil to brands that are targeted at the CBD medical market are meaningless. Kannaway CBD products are not for medical use; they are designed for everyday use.
Kannaway exceeds declared quantities of CBD on product labels – FDA
In 2015, the FDA examined CBD products on the US market. This was a random selection without any of the CBD companies knowing that this would take place, and the results were published in the Journal of Regulatory Science. The analysis revealed that Kannaway not only met but, in some cases, exceeded the amount of CBD stated on product labels.
No other supplier tested met or exceeded their product label claims in this product examination by the FDA. In fact, some had no CBD levels at all in their product, which is consistent with the trend of fake CBD products flooding the market.
Besides testing Kannaway’s Pure Gold product, the FDA held hearings in the run up to developing dietary supplement and pharmaceutical pathways for hemp and CBD in the US in 2019, and invited Kannaway CEO and Founder, Dr Stuart Titus to participate in his capacity as a long-standing expert in the industry.
Kannaway CBD levels explained
MediCann Slovakia and its partner Arge Canna refer to testing CBD per “drop”, which is highly unscientific and completely irrelevant. What’s important is how much CBD (in milligrams) there is per serving or per day. For example, the pharmaceutical version of CBD, known as Epidiolex, is a semi-synthetic version of CBD where the CBD is dosed by body weight – 25 mg per kilo of body weight.
This means that many young children are receiving 400-700 mg of CBD daily. If they were adults, they’d be receiving 1,500-2,000 mg of CBD on a daily basis. This high dose clearly shows the distinction between a medical product and a food-grade product. In fact, Epidiolex is a 12% concentration of CBD.
Pure Gold, on the other hand, in its 120 ml form, is a 1% concentration food oil. And Pure Gold, sold in 30 ml bottles, is a 2% concentration of CBD. These products are not intended to be sold based on a percentage concentration of CBD. The low CBD was chosen to create a safe, food-grade legal compliant product, providing 1,000 mg of CBD per bottle, which very much contrasts with the pharmaceutical version.
Kannaway recommends a 30 mg daily dose as part of an overall wellness maintenance routine – and this is the difference between a food-grade CBD product versus a pharmaceutical CBD product which is a much higher concentration. Kannaway is a lifestyle and wellness company whose CBD oil products are only aimed at the nutritional supplement market.
In addition, MediCann Slovakia and Arge Canna confuse their readers into thinking that Kannaway claims to produce and sell full-spectrum CBD oil, which is not the case. Kannaway’s Gold Oil is a broad-spectrum extract because it has had the THC removed, a process that in no way impairs the quality of the product.
For more information about Kannaway, its history, the products and the levels of CBD in Kannaway’s Pure Gold oil, you can watch a video presentation by Kannaway CEO and Founder, Dr Stuart Titus. You can also read more about the figures mentioned in this article relating to the levels of CBD in Pure Gold by clicking on this article.